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Abstract. Until recently, robotic surgery has been associated only with da Vinci robotic system. A novel Senhance® robotic system 
(TransEnterix Surgical Inc., Morrisville, NC, USA) has been introduced almost 5 years ago. Published reports on experience in colorectal 
surgery using this robotic platform is very limited. We present a prospective analysis of first 13 robotic colorectal surgeries in Klaipėda 
University Hospital, Klaipėda, Lithuania. 13 patients underwent various colorectal resections: 10 for colorectal cancer and 3 for colonic 
polyps. 7 were men and 6  women, age range 32–77 years, on an average 56 years. Among 10 patients with colorectal cancer, 3 had 
stage I, 3 stage II, 3 stage III and 1 stage IV colorectal cancer. 2 patients were operated for unremovable ascending colon adenomas and 
1 underwent prophylactic subtotal colectomy with ileorectal anastomisis for familial adenomatous polyposis. Complication occurred in 
1 case (7.7%). This patient underwent robotic abdominoperineal resection for low rectal cancer, developed postoperative bleeding from 
perineal wound on day 7 and had to be taken to operative room for oversuturing the bleeding vessel. Operative time was on an average 
3 hours 50 minutes, ranging from 2 hours and 55 minutes to 6 hours and 10 minutes. In-hospital stay ranged from 5 to 16 days, on an 
average 7 days.
Conclusion. Our experience with different types of robotic colorectal resections allows us to state that Senhance® robotic system is fea-
sible and safe for colorectal surgery, and wider implementation of this system in our specialty worldwide is simply a question of time.
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Robotinė kolorektinė chirurgija naudojant Senhance® robotinę sistemą: vieno centro 13 pirmųjų operacijų 
patirtis
Santrauka. Dar visai neseniai robotinė chirurgija buvo asocijuojama tik su da Vinci robotine sistema. Beveik prieš penkerius metus įdiegta 
Senhance® robotinė sistema (TransEnterix Surgical Inc., Morrisville, NC, USA). Kol kas yra labai nedaug mokslinių duomenų apie šios 
robotinės sistemos panaudojimą kolorektinėje chirurgijoje. 
Šiuo straipsniu pristatoma Klaipėdos universitetinėje ligoninėje atliktų pirmųjų 13 įvairių kolorektinių operacijų, naudojant Senhance® 
robotinę sistemą, perspektyvioji analizė. Iš 13 operuotų pacientų dešimt buvo operuoti dėl storosios žarnos vėžio, trys – dėl storosios 
žarnos polipų. Operuoti septyni vyrai ir šešios moterys, jų amžius – 32–77 m. (amžiaus vidurkis – 56 m.). Iš 10 pacientų, operuotų dėl storo-
sios žarnos vėžio, trys pacientai sirgo I stadijos vėžiu, trys – II stadijos vėžiu, trys – III stadijos vėžiu, vienas – IV stadijos vėžiu. Du pacientai 
operuoti dėl endoskopiškai nepašalinamų kylančiosios gaubtinės storosios žarnos dalies adenomų, vienam atlikta subtotalinė kolektomija 
su ileorektostomija dėl šeiminės adenominės polipozės. Komplikavosi vienos pacientės (7,7 %) pooperacinė eiga. Šiai pacientei septintą 
pooperacinę parą pradėjo kraujuoti iš tarpvietės pjūvio, todėl operacinėje persiūta kraujuojanti kraujagyslė. Vidutinė operacijų trukmė – 
3 val. ir 50 min., t. y. nuo 2 val. ir 55 min. iki 6 val. ir 10 min. Hospitalizacijos trukmė – nuo 5 iki 16 dienų (vidutiniškai – 7 dienos). 
Išvada. Įgyta patirtis, atlikus įvairių robotinių kolorektinių operacijų, leidžia teigti, kad Senhance® robotinė sistema yra saugi ir tinka ko-
lorektinei chirurgijai. Platesnis šios robotinės sistemos pritaikymas chirurgijoje visame pasaulyje, galima manyti, yra tik laiko klausimas.
Reikšminiai žodžiai: robotinė chirurgija, kolorektinė chirurgija, mažai invazinė chirurgija.
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Introduction
The possibility of performing minimally invasive (laparoscopic) colorectal surgery, including colon cancer, 
has been demonstrated more than a quarter of a century ago [1]. Since then and already quite a while ago, 
we learned about the safety of laparoscopic surgery for colon cancer [2–4]. There have been a number of tri-
als in favor of laparoscopic rectal cancer surgery, though two relatively recent non-inferiority trials have put 
certain doubt on laparoscopic rectal cancer surgery in comparison with the open approach [5–6]. Robotic 
colorectal surgery has long traditions as well, using da Vinci robotic system, which has been the only op-
tion for performing robotic surgery for years. The first robotic operation has been performed on a human 
in 1997 [7]. It seems to be reasonable to expect that robotic approach which has technological privileges 
including improved view and articulating instruments would help to perform surgeries in narrow spaces such 
as pelvis in rectal cancer surgery. There was a lot expected from ROLLARR randomized clinical trial [8] to 
give a solid background for this new type of surgery applied for rectal cancer, to demonstrate it superiority 
compared to conventional laparoscopy at least in terms of risk of conversion, but neither this nor secondary 
rectal cancer specific endpoints of this trial did show any difference between the two groups. The proof is 
still to be provided in future.
Robotic surgery using Senhance® robotic system (TransEnterix Surgical Inc., Morrisville, NC, USA) has 
been started in Klaipėda university hospital in Lithuania on November 19, 2018. In fact, first two robotic 
surgeries (first not only in Lithuania and in the Baltic countries as well) were colorectal resections for colon 
and rectal tumors. Since the first single center series on colorectal surgery using this robotic system in the 
world [9] there have been just a couple more, and we hope that this article on our first experience in Klaipėda 
will add to the evidence of feasibility of this robotic system for colorectal surgery.
Patients and methods
Prior to the start of robotic surgery with Senhance® robotic system in Klaipėda University Hospital, our team 
(divided into two separate groups) consisting of two surgeons, two gynecologists, two urologists, three scrub 
nurses and two anesthesiologists went to the Senhance® training center in Milan, Italy. Training consisting 
of introduction to this robotic platform and a hands-on two day dry lab training with third day wet lab, 
performing various surgical procedures with this system on pigs, having a proctor who had large experience 
with this kind of surgery on humans. 
November 19, 2018 to April 1, 2019 more than 100 procedures using Senhance® robotic platform have 
been performed in general and colorectal surgery, gynecology and urology. Among them, 13 patients un-
derwent various colorectal resections: 10 for colorectal cancer and 3 for colonic polyps. 7 were men and 6 
women, age range 32–77 years, on an average 56 years. Among 10 patients with colorectal cancer, 3 had 
stage I, 3 stage II, 3 stage III and 1 stage IV colorectal cancer. 2 patients were operated for unremovable 
ascending colon adenomas and 1 underwent prophylactic subtotal colectomy with ileorectal anastomosis 
for familial adenomatous polyposis. All selected patients would otherwise undergo laparoscopic surgery. In-
formed consent was obtained in each case. Robotic surgery was started in each case like a typical laparoscopic 
case, inserting the first trocar just below the umbilicus, creating pneumoperitoneum and investigating the 
abdominal cavity. Other trocars were inserted depending on the type of surgery which was planned to be 
performed, trying to put two working port of the robotic arms a bit further away from the operation field in 
comparison to laparoscopic approach. After all the trocars were in place, robotic arms were docked. In all cases 
performed, so far we used only 3 robotic arms. For the right hemicolectomy, all the three robotic arms were 
on the left side of the patient. For sigmoid and rectal resections, one robotic arm was on the right side and 
two on the left side. While performing subtotal colectomy, we used the same position of the robotic arms as 
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for the latter surgery, but we had to re-dock the arms several times during this more complex multiquadrant 
procedure. In the cases of right hemicolectomy, both ligation of the vessels and anastomosis were performed 
after making a 5 to 6 cm transumbilical incision and exteriorizing the surgical specimen. In cases of sigmoid 
and rectal resections, ligation of vessels was performed laparoscopically after mobilizing the inferior mesen-
teric artery and vein using Echelon 60 stapling device. In case of prophylactic subtotal colectomy for familial 
adenomatous polyposis, colon was mobilized close to serosa using Lotus robotic energy source. After sigmoid 
resection or anterior rectal resection with partial mesorectal excision (PTME) anastomosis was performed 
laparoscopically using Ethicon 29 or 33 circular stapling device. After TaTME, manual colo-anal side to end 
anastomosis was performed.
Results
From 13 operations performed, complication occurred in 1 case (7.7%). This patient underwent robotic 
abdominoperineal resection for low rectal cancer, developed postoperative bleeding from perineal wound 
on day 7 and had to be taken to operative room for oversuturing the bleeding vessel. Operative time was on 
an average 3 hours 50 minutes, ranging from 2 hours and 55 minutes for right hemicolectomy to 6 hours 
and 10 minutes for subtotal colectomy with ileorectal anastomosis. In rectal cancer cases, neither distal nor 
circumferential margins were compromised. Both patient who underwent TaTME were after long course ra-
diochemotherapy – one underwent TaTME 8 weeks after neoadjuvant treatment and no response, the second 
one had a recurrence after complete response being in a ‘watch and wait’ group. In-hospital stay ranged from 
5 to 16 days, on an average 7 days. More detailed information about our 13 patients is delineated in Table 1.
Table 1. Data on 13 robotic procedures
Case Patient characteristics(sex, age) Procedure Final histology
Lymph node  
harvest
1 F, 58 Anterior rectal resection with partial TME pT1N0 15
2 F, 77 Right hemicolectomy Adenoma with high grade dysplasia n/a
3 M, 54 Anterior resection with partial TME (Hartman procedure)
Liver and peritoneal 
metastasis 19 (5 mts)
4 M, 54 Right hemicolectomy pT2No 22
5 F, 52 Abdominoperineal resection pT2N0 10
6 F, 68 Right hemicolectomy pT3N0 16
7 F, 67 Sigmoid resection pT4N1 12 (2 mts)
8 F, 48 Right hemicolectomy pT3N0 26
9 M, 32 Subtotal colectomy Multiple colonic adenomas n/a
10 M, 72 Right hemicolectomy pT3N1 23 (3 mts)
11 M, 50 TaTME ypT2N2 16 (4 mts)
12 M, 51 Right hemicolectomy Adenoma n/a
13 M, 46 TaTME ypT3N0 10
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Discussion
Senhance® robotic system has first been used in gynecological surgery and report about this experience has 
been published in 2015 [10]. Spinelli et al. [9] was the first to report experience in colorectal surgery with Sen-
hance®, which showed it to be feasible for this type of surgery as well. From 45 colorectal resections performed 
by his group, 2/3 were performed for colorectal cancer. There were only 4 conversions, which included 3 to 
laparoscopy and only 1 to open surgery. Major complications (Calvien-Dindo III) occurred only in 2 cases. 
Other important experience comes from Siegen in Germany [11], where 116 abdominal robotic surgeries 
were performed over a period of 6 months in 2016. They started colorectal resections with sigmoid colectomy 
for diverticular disease only after gaining experience with 100 less complicated general surgical procedures. 
FDA approval for this robotic platform came in 2018, and first published article on US experience included 
only 2 colorectal resections [12]. Of course, our experience is very limited as well, but so far we didn’t have 
major complications and there was no need for conversion. Even starting other abdominal procedures at the 
same time and not having a possibility to get larger experience with the platform with more simple general 
surgical procedures, we performed a variety of different and complicated colorectal procedures, and after this 
experience, only our right hemicolectomy seems to bet closer to more or less routine procedure for us. This 
was the reason for longer duration of the operating time. Our pathological specimens were adequate and in 
no case oncologic safety was compromised among 10 patients undergoing robotic surgery for cancer.
Conclusion
Our experience with different types of robotic colorectal resections allows us to state that Senhance® robotic 
system is feasible and safe for colorectal surgery, and wider implementation of this system in our specialty 
worldwide is simply a question of time.
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